FDA Sets Limits on Fecal Matter Transplant

Drug Industry Daily
A A
The FDA is proposing that physicians be allowed to perform fecal matter transplants (FMT) in limited circumstances without an investigational new drug (IND) application, provided the physician or their patient knows the donor.

To View This Article:

Login

Subscribe To Drug Industry Daily